e-learning
resources
London 2016
Monday, 05.09.2016
Microbiological issues and translational research in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Real-life effectiveness data on prevention OF COPD and asthma exacerbations with 13-valent pneumococcal conjugate vaccine (PCV13)
Miguel Angel Hernandez Mezquita (Aldeatejada, Spain), Miguel Angel Hernandez Mezquita, Alexis Morales Boscam, Vanesa Hidalgo Sierra, Mercedes Sobrino Ballesteros, Miguel Barrueco Ferrero
Source:
International Congress 2016 – Microbiological issues and translational research in respiratory infections
Session:
Microbiological issues and translational research in respiratory infections
Session type:
Thematic Poster
Number:
2632
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Miguel Angel Hernandez Mezquita (Aldeatejada, Spain), Miguel Angel Hernandez Mezquita, Alexis Morales Boscam, Vanesa Hidalgo Sierra, Mercedes Sobrino Ballesteros, Miguel Barrueco Ferrero. Real-life effectiveness data on prevention OF COPD and asthma exacerbations with 13-valent pneumococcal conjugate vaccine (PCV13). Eur Respir J 2016; 48: Suppl. 60, 2632
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Effectiveness data on prevention of COPD exacerbations with 13-valent pneumococal conjugate vaccine (PCV13)
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Year: 2017
Pneumococcal vaccination: Effects on exacerbation of COPD
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Efficacy of influenza and pneumococcal vaccinations among patients with COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007
Impaired response to 13-valent pneumococcal conjugate vaccine (PCV13) in children with recurrent respiratory infections and chronic cough.
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021
Clinical efficacy of pneumococcal conjugate vaccine in patients with chronic airway disease
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014
Influenza and pneumococcal vaccination in patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Pneumococcal vaccine in steroid-dependent COPD
Source: Annual Congress 2005 - Acute and chronic infections in COPD
Year: 2005
Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
The importance of pneumococcal and influenza vaccines in patients with allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 376s
Year: 2005
Effectiveness of a 23-valent pneumococcal polysaccharide vaccine and a 13-valent pneumococcal conjugate vaccine among the elderly with chronic respiratory diseases
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012
Comparison of efficacy of grippe vaccination and broncho vaxom administration in COPD patients
Source: International Congress 2015 – Different data in COPD
Year: 2015
No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 292s
Year: 2005
Australian perceptions of pertussis and vaccine preventable disease in the setting of asthma and COPD
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Pneumococcal polysaccharide vaccination in COPD patients - some problems with antibody-response
Source: Eur Respir J 2002; 20: Suppl. 38, 472s
Year: 2002
Compliance with the pneumococcal and influenza vaccination recommendations in patients with COPD in Catalonia (Spain)
Source: Eur Respir J 2005; 26: Suppl. 49, 594s
Year: 2005
Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects
Source: Eur Respir J 2005; 26: 1086-1091
Year: 2005
Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013
Analysis of the Effect of pneumococcal vaccination in patients with COPD in combination with bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept